Page last updated: 2024-11-07

3-mercapto-2-methylpropionic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-mercapto-2-methylpropionic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID152910
CHEMBL ID3100057
SCHEMBL ID161586
MeSH IDM0154592

Synonyms (42)

Synonym
3-mercapto-2-methyl propanoic acid
3-mercaptoisobutyric acid
2-methyl-3-sulfanylpropanoic acid
inchi=1/c4h8o2s/c1-3(2-7)4(5)6/h3,7h,2h2,1h3,(h,5,6)
mhrdchhesnjqis-uhfffaoysa-
M1200
26473-47-2
3-mercapto-2-methylpropionic acid
A5246
3-mercapto-2-methylpropanoic acid
unii-v3e4016vas
einecs 247-726-6
v3e4016vas ,
AKOS009159080
3-mercaptoisobutyricacid
FT-0615948
propionic acid, 3-mercapto-2-methyl-
propanoic acid, 3-mercapto-2-methyl-
(2rs)-2-methyl-3-sulfanylpropanoic acid
captopril impurity c [ep impurity]
isobutyric acid, .beta.-mercapto-
(+/-)-3-mercapto-2-methylpropionic acid
MHRDCHHESNJQIS-UHFFFAOYSA-N
2-methyl-3-sulfanyl-propanoic acid
SCHEMBL161586
CHEMBL3100057
captopril ep impurity c
2-methyl-3-sulfanylpropanoic acid, aldrichcpr
mfcd00671555
(2rs)-2-methyl-3-sulfanyl-propanoic acid
J-016445
3-mercapto-2-methylpropansaure
DTXSID60865293
Q27291489
D91461
captopril impurity c
EN300-91800
CS-0141858
HY-137769
3-mercapto-2-methylpropanoicacid
mercaptoisobutyricacid; 98%
Z808230868
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1060453Inhibition of NDM-1 (unknown origin) using imipenem as substrate by spectrophotometric analysis2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Simplified captopril analogues as NDM-1 inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (10.00)18.7374
1990's3 (30.00)18.2507
2000's1 (10.00)29.6817
2010's2 (20.00)24.3611
2020's3 (30.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.80 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index5.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]